Dynamic Advisor Solutions LLC boosted its stake in Cencora, Inc. (NYSE:COR – Free Report) by 15.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,166 shares of the company’s stock after acquiring an additional 154 shares during the period. Dynamic Advisor Solutions LLC’s holdings in Cencora were worth $262,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Rise Advisors LLC purchased a new stake in shares of Cencora during the first quarter worth approximately $25,000. New Millennium Group LLC acquired a new position in Cencora in the 2nd quarter valued at $26,000. TCTC Holdings LLC purchased a new position in Cencora during the 1st quarter worth $29,000. TFO Wealth Partners LLC acquired a new stake in shares of Cencora in the 1st quarter worth $30,000. Finally, MFA Wealth Advisors LLC purchased a new stake in shares of Cencora in the second quarter valued at about $30,000. 97.52% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other news, EVP Silvana Battaglia sold 1,473 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $242.69, for a total value of $357,482.37. Following the sale, the executive vice president now directly owns 10,948 shares in the company, valued at $2,656,970.12. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Silvana Battaglia sold 1,473 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $242.69, for a total value of $357,482.37. Following the completion of the transaction, the executive vice president now owns 10,948 shares of the company’s stock, valued at $2,656,970.12. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Steven H. Collis sold 10,755 shares of Cencora stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $222.12, for a total transaction of $2,388,900.60. Following the completion of the sale, the chief executive officer now directly owns 285,088 shares of the company’s stock, valued at $63,323,746.56. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,450,399 shares of company stock valued at $1,070,392,799. Corporate insiders own 15.80% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on COR
Cencora Trading Up 0.2 %
NYSE:COR opened at $222.56 on Monday. Cencora, Inc. has a 52-week low of $182.75 and a 52-week high of $247.66. The company has a quick ratio of 0.55, a current ratio of 0.89 and a debt-to-equity ratio of 3.93. The stock has a fifty day simple moving average of $232.97 and a 200-day simple moving average of $231.40. The company has a market capitalization of $44.39 billion, a PE ratio of 24.35, a price-to-earnings-growth ratio of 1.40 and a beta of 0.44.
Cencora (NYSE:COR – Get Free Report) last announced its earnings results on Wednesday, July 31st. The company reported $3.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.18 by $0.16. The company had revenue of $74.20 billion during the quarter, compared to analysts’ expectations of $73.32 billion. Cencora had a net margin of 0.65% and a return on equity of 266.60%. The firm’s quarterly revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.92 earnings per share. On average, equities research analysts expect that Cencora, Inc. will post 13.63 earnings per share for the current fiscal year.
Cencora Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, August 26th. Shareholders of record on Friday, August 9th were issued a dividend of $0.51 per share. This represents a $2.04 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date was Friday, August 9th. Cencora’s dividend payout ratio (DPR) is presently 22.32%.
About Cencora
Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Read More
- Five stocks we like better than Cencora
- Stock Analyst Ratings and Canadian Analyst Ratings
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- How to Use the MarketBeat Dividend Calculator
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Want to see what other hedge funds are holding COR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cencora, Inc. (NYSE:COR – Free Report).
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.